Breakthrough medical device that transforms treatment of intracranial bleeding recognized as most innovative new medical device from southern California.
IRRAS AB, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that IRRAflow has been selected as the 2019 winner of CONNECT’s Most Innovative New Product award in the medical device category. CONNECT, a premier nonprofit helping entrepreneurs with innovative startups in the technology and life sciences sectors, continues its thirty-two-year tradition of celebrating innovation leaders in the broader San Diego area.
IRRAflow, the company’s initial commercial product, has a unique mechanism of action that addresses the complications associated with the current methods of managing intracranial fluid by using a dual-lumen catheter that combines automated irrigation, controlled drainage, and continuous ICP monitoring, all into one system.
“Our IRRAS team has worked extremely hard to build the foundation for a legacy company, and it was an honor to be recognized by our entrepreneurial peers,” said Will Martin, IRRAS’ Chief Commercial Officer. “At IRRAS, we are committed to bringing needed innovation to neurocritical care and this recognition confirms our commitment.”
IRRAflow was awarded in the medical device category at the annual Innovation Awards event held on Thursday, December 5th, at the Hyatt Regency La Jolla at Aventine. Winners were selected in the following seven categories: Big Data; Cleantech; Defense; Medical Device; Life Science and Healthtech; Smart City & Transportation, and Software.
For a complete list of winners and additional information, please visit the CONNECT’s website.
About IRRAS
IRRAS AB is a global healthcare company focused on delivering innovative medical technologies to our customers and their patients. IRRAS designs, develops and commercializes products that improve patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methods in neurocritical care. IRRAS markets and sells its products to hospitals worldwide through its direct sales organizations in the U.S. and select European countries and a network of distribution partners in other markets.
See Full Press Release: IRRAflow[®] Wins CONNECT’s “2019 Most Innovative New Product” Award | IRRAS
Written by: IRRAS
Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.
We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.
Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.